A Better Newspaper

## Andrew Left Criminal Securities Fraud Trial Short seller Andrew Left is facing criminal securities fraud charges in a trial that has significant implications for the short-selling industry and the legality of trading on one's own published research. ### Trial Testimony Left told jurors that he does not believe there is anything wrong with him profiting from the 'price correction' of a stock after he issues a report or tweet about a company he thinks is overvalued or undervalued (Bloomberg, May 26, 2026). He testified that no law barred him from trading after publishing research (Bloomberg, May 26). ### Core Legal Issue The prosecution's theory reportedly centers on whether Left's trading against his own published positions constituted fraud on readers or the market. Left's defense is that his trades were consistent with his public commentary and that no statute prohibits the practice. ### Industry Significance - Left is founder of Citron Research, one of the most prominent activist short-selling publications in the US - The case is being closely watched by the short-selling community as a potential precedent on the legality of monetizing research through coordinated trading - A conviction could chill activist short-selling, which proponents argue serves a market integrity function by exposing overvalued or fraudulent companies - Acquittal would affirm the legality of the trading-alongside-publication model used by many short sellers ### Background Left built his reputation publishing bearish research on companies he believed were overvalued or engaged in misconduct. The DOJ's decision to criminally charge him marked an escalation in scrutiny of activist short sellers. ### Open Questions - Verdict and potential sentencing remain pending - Whether the case will generate appellate precedent on the legality of short-seller trading models - Regulatory follow-on by the SEC remains possible regardless of criminal outcome